202 related articles for article (PubMed ID: 20353977)
1. Domain I of beta2-glycoprotein I: its role as an epitope and the potential to be developed as a specific target for the treatment of the antiphospholipid syndrome.
Ioannou Y; Rahman A
Lupus; 2010 Apr; 19(4):400-5. PubMed ID: 20353977
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic role of anti-beta2-glycoprotein I antibodies on human placenta: functional effects related to implantation and roles of heparin.
Di Simone N; Meroni PL; D'Asta M; Di Nicuolo F; D'Alessio MC; Caruso A
Hum Reprod Update; 2007; 13(2):189-96. PubMed ID: 17099207
[TBL] [Abstract][Full Text] [Related]
3. Anti-beta-2 glycoprotein I epitope specificity: from experimental models to diagnostic tools.
Meroni PL
Lupus; 2016 Jul; 25(8):905-10. PubMed ID: 27252268
[TBL] [Abstract][Full Text] [Related]
4. The IgA Isotype of Anti-β2 Glycoprotein I Antibodies Recognizes Epitopes in Domains 3, 4, and 5 That Are Located in a Lateral Zone of the Molecule (L-Shaped).
Serrano M; Martinez-Flores JA; Norman GL; Naranjo L; Morales JM; Serrano A
Front Immunol; 2019; 10():1031. PubMed ID: 31134087
[No Abstract] [Full Text] [Related]
5. TLR4 is involved in the pathogenic effects observed in a murine model of antiphospholipid syndrome.
Xie H; Kong X; Zhou H; Xie Y; Sheng L; Wang T; Xia L; Yan J
Clin Immunol; 2015 Oct; 160(2):198-210. PubMed ID: 26065621
[TBL] [Abstract][Full Text] [Related]
6. New targeted therapies for treatment of thrombosis in antiphospholipid syndrome.
Pierangeli SS; Vega-Ostertag ME; González EB
Expert Rev Mol Med; 2007 Nov; 9(30):1-15. PubMed ID: 17997880
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
8. Antiphospholipid syndrome: long-time research on pathogenic mechanisms has finally lead to new therapeutic strategies.
Cervera R; Espinosa G
Expert Opin Ther Targets; 2010 Dec; 14(12):1279-82. PubMed ID: 21058919
[TBL] [Abstract][Full Text] [Related]
9. Some antiphospholipid antibodies recognize conformational epitopes shared by beta2-glycoprotein I and the homologous catalytic domains of several serine proteases.
Lin WS; Chen PC; Yang CD; Cho E; Hahn BH; Grossman J; Hwang KK; Chen PP
Arthritis Rheum; 2007 May; 56(5):1638-47. PubMed ID: 17469158
[TBL] [Abstract][Full Text] [Related]
10. Antibodies against domain I of β2-glycoprotein I: the one and only?
Pelkmans L; de Laat B
Lupus; 2012 Jun; 21(7):769-72. PubMed ID: 22635228
[TBL] [Abstract][Full Text] [Related]
11. Current management of antiphospholipid syndrome-related thrombosis.
Puente D; Pombo G; Forastiero R
Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1551-8. PubMed ID: 19954317
[TBL] [Abstract][Full Text] [Related]
12. Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms.
Pierangeli SS; Chen PP; Raschi E; Scurati S; Grossi C; Borghi MO; Palomo I; Harris EN; Meroni PL
Semin Thromb Hemost; 2008 Apr; 34(3):236-50. PubMed ID: 18720303
[TBL] [Abstract][Full Text] [Related]
13. Venous thrombosis in the antiphospholipid syndrome.
Farmer-Boatwright MK; Roubey RA
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):321-5. PubMed ID: 19228605
[TBL] [Abstract][Full Text] [Related]
14. Complement and the antiphospholipid syndrome.
Lim W
Curr Opin Hematol; 2011 Sep; 18(5):361-5. PubMed ID: 21730831
[TBL] [Abstract][Full Text] [Related]
15. [Pathogenic mechanisms of the anti-phospholipid antibodies].
Núñez-Álvarez CA; Cabiedes J
Reumatol Clin; 2011; 7(1):72-6. PubMed ID: 21794784
[TBL] [Abstract][Full Text] [Related]
16. Autoantibody explosion in antiphospholipid syndrome.
Shoenfeld Y; Twig G; Katz U; Sherer Y
J Autoimmun; 2008; 30(1-2):74-83. PubMed ID: 18171610
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma--consequences for the development of anti-beta2-glycoprotein I antibodies.
Horbach DA; van Oort E; Tempelman MJ; Derksen RH; de Groot PG
Thromb Haemost; 1998 Nov; 80(5):791-7. PubMed ID: 9843173
[TBL] [Abstract][Full Text] [Related]
18. Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment.
Asherson RA; Cervera R; Merrill JT; Erkan D
Semin Thromb Hemost; 2008 Apr; 34(3):256-66. PubMed ID: 18720305
[TBL] [Abstract][Full Text] [Related]
19. Novel considerations in the pathogenesis of the antiphospholipid syndrome: involvement of the tissue factor pathway of blood coagulation.
Adams M
Semin Thromb Hemost; 2008 Apr; 34(3):251-5. PubMed ID: 18720304
[TBL] [Abstract][Full Text] [Related]
20. The role of TLR4 in pathophysiology of antiphospholipid syndrome-associated thrombosis and pregnancy morbidity.
Xie H; Sheng L; Zhou H; Yan J
Br J Haematol; 2014 Jan; 164(2):165-76. PubMed ID: 24180619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
